Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
about
Paraneoplastic neurological syndromesSpectrum of centrosome autoantibodies in childhood varicella and post-varicella acute cerebellar ataxia'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIIIRNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assayAutoimmune dementia: clinical course and predictors of immunotherapy responseSerologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotilityUpdate on the endoscopic treatments for achalasia.Paraneoplastic movement disordersDiagnosis and management of adult patients with chronic intestinal pseudoobstructionSensory neuronopathies.Feeding-dependent activation of enteric cells and sensory neurons by lymphatic fluid: evidence for a neurolymphocrine system.Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromesNeural autoantibody profile of primary achalasiaInterstitial cells of Cajal in human gut and gastrointestinal disease.Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature.Paraneoplastic syndromes associated with lung cancerPathophysiology of achalasia.Paraneoplastic syndromes of the spinal cord, nerve, and muscle.Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.Antibody testing as a diagnostic tool in autonomic disorders.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control studyCurrent approaches to the treatment of paraneoplastic encephalitis.Autonomic dysfunction in peripheral nerve disease.Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.Neurologic paraneoplastic syndromes.Management of paraneoplastic syndromes in lung cancer.Lymphoma and peripheral neuropathy: a clinical review.Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review.Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig.Immune-mediated autonomic neuropathies.Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma.An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.Diagnosis and current treatment of neurological paraneoplastic syndromes.The TGR5 receptor mediates bile acid-induced itch and analgesiaEnteric autoantibodies and gut motility disorders.Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system
P2860
Q21093169-FB4C0F3D-6C4F-4DC6-9544-986FB725E0D7Q21260344-09FE9190-D543-4373-B7B4-11CFB91D6598Q22000623-4F5B209B-289F-4ADB-B30F-2F2F9C28DC8CQ22253321-78C55244-F8BF-4D4E-B56A-002356F1F938Q24597504-1F31B05C-186C-476F-8B11-A7E2DF3C8A7AQ24657404-28B9BB59-B669-46DE-8C25-0079C0A457E4Q28075534-1C56289F-A84E-46EF-98AB-1B51CDB257BDQ28250201-BAE6D60D-65BE-46E1-9FEF-74DC6DB0B48BQ28293980-9C3222AD-8E6B-4C64-94FE-EBE7E489BF91Q30278525-C912626A-A031-4205-B0C2-D9C8D450DAE0Q30576325-49AB0AEE-78B3-4B1B-97A9-D70E60D8A791Q33216878-23C2DD99-983A-4093-9CC2-6C29EEB45496Q33641955-7542C727-8415-4E15-95A6-FED0BF033273Q33797034-2D7522E8-7439-48F4-A717-73DE294261A4Q33865718-F292B6DC-9996-4CEF-BD47-C0951D3C439FQ34023610-B5ED8EFC-8B30-4E05-8F30-5EEC84D4D3ABQ34027704-DBEB4883-FE44-4BC6-9826-D475AD854685Q34096509-C910859D-3866-4E2F-B002-E95F726BE1FCQ34111688-92B7D54F-FECF-42FB-8013-9F5EC9A6A107Q34219323-FC0BBDCF-CA57-4E31-BCA5-DA6B2C884B4DQ34404847-B8EFDB26-08BC-4F4C-A518-3301C4E8BEA3Q34570109-2A9DCC8F-0820-4DC1-A04C-716A7B450526Q34813320-9DEC814F-54FE-4656-A2CB-6304658726B8Q34826137-38D9AB21-2DFA-4DC5-BC9D-08A6F18E8DF6Q34951927-914C2653-6BE0-4D0F-A42E-EC3B576B4620Q35090428-807A1E5A-2B8D-4675-9C9B-2743E4D22E90Q35136074-495FB9C7-2E15-418E-83FC-8D2F8561A057Q35451934-DD589EA1-3101-45E1-8871-6A3F30567701Q35603875-99658B4C-9E4C-433F-A14B-98348066C9FAQ35617154-0C82CA1E-9318-46FB-82B0-041DB39B0FA9Q35949252-8F97BBF0-2D45-43A9-AA71-F20038C15BF2Q36020020-48CDFB24-BF53-4FA7-A969-B2E9FA389B46Q36065514-C0BE3692-E959-4B6E-AB74-02BB9296B593Q36392297-E0CFAA16-62ED-4B4D-A432-7B77288A370AQ36515857-ED16AECB-44AF-40E8-A83B-6EACFF021019Q36648834-9FC52B94-F627-4686-877F-1AC93A0CA138Q36668497-8C3FCC04-6D34-4423-B1F8-691B3CD7DF59Q36733406-611ADB62-DD8F-4124-A942-49DE296553CAQ36750462-10CD994B-DB7D-4154-A656-AA5ECC52BB75Q36812520-8C74032D-4A62-48E1-8C22-A67D29275A62
P2860
Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@en
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@nl
type
label
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@en
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@nl
prefLabel
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@en
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@nl
P2093
P356
P1433
P1476
Paraneoplastic and oncologic p ...... uronal nuclear autoantibodies.
@en
P2093
Lucchinetti CF
P304
P356
10.1212/WNL.50.3.652
P407
P577
1998-03-01T00:00:00Z